(Q34254679)

31 July 2017

1 reference

title

Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives (English)

1 reference

31 July 2017

1 reference

1 reference

Davis AR

1

1 reference

PubMed ID

11358700

31 July 2017

Westhoff CL

series ordinal

2

1 reference

PubMed ID

11358700

31 July 2017

language of work or name

1 reference

1 February 2001

1 reference

Journal of Pediatric and Adolescent Gynecology

31 July 2017

1 reference

31 July 2017

14

1 reference

31 July 2017

1

1 reference

31 July 2017

3-8

1 reference

The incidence of primary dysmenorrhea in teenagers

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

A survey of adolescent dysmenorrhea and premenstrual symptom frequency. A model program for prevention, detection, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Use of medication by adolescents for the management of menstrual discomfort

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

An epidemiologic study of young women with dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Level of knowledge among adolescent girls regarding effective treatment for dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Socioeconomic Implications of Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

New concepts in dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Non-pharmacologic Strategies Used by Adolescents for the Management of Menstrual Discomfort

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

1 reference

7 January 2021

Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Intra-uterine pressure in dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea--a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Clinical evaluation of a new model of a transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Ketoprofen, ibuprofen, and placebo in the treatment of primary dysmenorrhea: a double-blind crossover comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Zomepirac sodium in the treatment of primary dysmenorrhea syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Effect of various oral contraceptive combinations on dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Clinical experience with a triphasic oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

Dynamics and significance of placebo response in primary dysmenorrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

1 reference

7 January 2021

Teenage pregnancy in developed countries: determinants and policy implications

1 reference

https://api.crossref.org/works/10.1016%2FS1083-3188%2800%2900076-0

7 January 2021

10.1016/S1083-3188(00)00076-0

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11358700